Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
11/2003
11/26/2003EP1363888A2 Therapeutic acridone and acridine compounds
11/25/2003CA2261032C Dibenzodihydropyridinecarboxylic esters and their use in chemiluminescent assay methods
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/06/2003US20030207909 Therapeutic acridone and acridine compounds
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
10/2003
10/28/2003US6638935 Heteroary1 derivatives and their use as medicaments
10/22/2003EP1353908A1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives
10/21/2003US6635437 Useful in methods for producing light and in assays for phosphatase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/08/2003EP1349838A1 Bistable tricyclic molecules with an appended rotor activated by an electrical field for electronic switching, gating and memory applications
10/08/2003CN1447796A Novel heteroaryl derivatives and use thereof as anti-tumour agents
10/07/2003US6630481 Phototherapeutic and catalytic photoactivated DNA cleaving agents
10/07/2003US6630464 Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer
10/02/2003WO2002008193A3 Therapeutic acridone and acridine compounds
09/2003
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/24/2003CN1122024C Process for converting hydroxy heteroaromatics to arylamines
09/23/2003US6624002 Bistable molecular mechanical devices with an appended rotor activated by an electric field for electronic switching, gating and memory applications
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/17/2003EP1343846A1 Dyeing or printing of manufactured natural polymer and synthetic hydrophobic fibre materials
09/17/2003CN1443172A Novel heteroaryl derivatives and use thereof as pharmaceuticals
09/17/2003CN1443171A Novel heteroaryl derivatives and use thereof as pharmaceuticals
09/16/2003US6620936 9-aminoacridine derivatives and process for the preparation thereof
09/12/2003WO2003074490A1 9-aminoacridine derivatives and process for the preparation thereof
09/11/2003US20030170771 Compounds for generating chemiluminescence with a peroxidase
09/11/2003US20030170762 Compounds for generating chemiluminescence with a peroxidase
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/04/2003US20030164173 Reduced ignition propensity smoking article
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1339800A1 Squaraine based dyes and process for preparation thereof
09/03/2003EP1339689A1 N-type calcium channel antagonists for the treatment of pain
09/02/2003US6613797 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
08/2003
08/27/2003CN1438882A Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
08/21/2003US20030158127 Aromatic sulfenates for type I phototherapy
08/19/2003CA2201595C Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences
08/07/2003US20030149073 Cycloalkano-indole and -azaindole derivatives
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
07/2003
07/30/2003EP1330440A1 Agent which inactivates pathogens, comprising an element that bonds with nucleic acids and the use thereof
07/30/2003CN1433396A Pharmaceutical compounds
07/30/2003CN1116285C Bis (acridinecarboxamide) and Bis (phenazinecarboxamide) as antitumour agents
07/24/2003WO2003059885A1 Therapeutic acridone and acridine compounds
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003CA2473170A1 Therapeutic acridone and acridine compounds
07/17/2003WO2003039488A3 A method for treating inflammatory bowel disease
07/15/2003US6593324 Dervatives of quinoline as alpha-2 antagonists
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/09/2003CN1429210A Substituted thioacetamides
07/09/2003CN1113871C 9-aminoacridine derivatives and process for preparation thereof
07/08/2003US6589961 9-alkylamino-1-nitroacridine derivatives
07/03/2003WO2003053934A1 Improved compounds for generating chemiluminescence with a peroxidase
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/02/2003EP1322670A1 Electrochemiluminescence from acridan compounds
06/2003
06/25/2003EP1029016A4 Novel chemiluminescent labeling compounds
06/24/2003US6583286 Method for hydrogenating unsaturated heterocyclic compounds
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/18/2003EP1255757B1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
06/18/2003EP1021414B1 Frangible compounds for pathogen inactivation
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/10/2003US6576192 Fluoroionophores and their use in optical ion sensors
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003CA2468159A1 4-aminoquinoline compounds
05/2003
05/29/2003US20030100779 Process for preparing pentacene derivatives
05/27/2003US6569880 Bis(benzimidazole) derivatives serving as potassium blocking agents
05/22/2003US20030097010 Cyclizing at least one substituted bis(benzyl)phthalic acid to form the corresponding substituted pentacenedione by using an acid composition comprising trifluoromethanesulfonic acid to produce pentacene derivative
05/15/2003WO2003039546A1 New uses for anti-malarial therapeutic agents
05/15/2003WO2003039488A2 A method for treating inflammatory bowel disease
05/15/2003US20030092060 Chemiluminescent compounds and use thereof
05/15/2003US20030089920 Tricyclic fused ring compounds of given formula, for example, 10-(aminocarbonyl)-9,10-dihydroacridine
05/15/2003CA2465948A1 A method for treating inflammatory bowel disease
05/14/2003EP1140888B1 Optical molecular sensors for cytochrome p450 activity
05/08/2003WO2003038399A2 Chemiluminescent acridinium compounds and their use in an assay to detect analytes
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2002008194A8 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
05/08/2003US20030087858 Diagnostic and therapeutic compositions for alzheimer's disease
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP0889863B1 Surface modified carbonate materials
05/02/2003EP1305290A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
05/02/2003EP1305289A2 Novel heteroaryl derivatives and use thereof as anti-tumour agents
05/01/2003WO2003035768A1 Squaraine based dyes and process for preparation thereof
04/2003
04/30/2003CN1414956A Substituted piperazine derivatives as MIP inhibitors
04/29/2003US6555663 Prodrugs for selective drug delivery
04/16/2003EP1301485A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
04/15/2003US6548515 Use as anticancer agents
04/10/2003US20030066988 Electroconductivity coloring
04/09/2003EP0850224B1 Radiation-activated cytotoxin therapy
04/08/2003US6544745 Monitoring, detecting, screening and determining pancreatic defects in humans; obtain and determine nucleotide sequence of sample, compare to control, detect mutation, evaluate human for pancreatic defects
04/03/2003WO2003027050A2 Process for preparing pentacene derivatives
04/02/2003EP0819119B1 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
04/01/2003US6541483 Acridone-derived compounds useful as antineoplastic and antiretroviral agents
03/2003
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003CA2460151A1 Cytokine receptor
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055087 As analgesic
03/20/2003US20030055086 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/20/2003US20030054200 Organic electroluminescence device
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/19/2003EP1292573A2 Substituted thioacetamides
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 22